Cargando…
Whole-Blood Gene Expression Profiles Correlate with Response to Immune Checkpoint Inhibitors in Patients with Metastatic Renal Cell Carcinoma
SIMPLE SUMMARY: Some metastatic renal cell carcinoma (mRCC) patients do not respond to immune checkpoint inhibitor (ICI) therapy. However, since predicting who will be a poor responder is difficult, a non-invasive, high-resolution genomic biomarker to accurately predict clinical responses to ICIs is...
Autores principales: | Nagumo, Yoshiyuki, Kandori, Shuya, Kojima, Takahiro, Hamada, Kazuki, Nitta, Satoshi, Chihara, Ichiro, Shiga, Masanobu, Negoro, Hiromitsu, Mathis, Bryan J., Nishiyama, Hiroyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776722/ https://www.ncbi.nlm.nih.gov/pubmed/36551692 http://dx.doi.org/10.3390/cancers14246207 |
Ejemplares similares
-
Variant allele frequency changes in TP53 predict pembrolizumab response in patients with metastatic urothelial carcinoma
por: Hamada, Kazuki, et al.
Publicado: (2023) -
Glucocorticoids coordinate the bladder peripheral clock and diurnal micturition pattern in mice
por: Chihara, Ichiro, et al.
Publicado: (2023) -
Laparoendoscopic single‐site surgery for urachal remnant with extraperitoneal approach through a suprapubic port
por: Hoshi, Akio, et al.
Publicado: (2022) -
ELOVL5‐mediated fatty acid elongation promotes cellular proliferation and invasion in renal cell carcinoma
por: Nitta, Satoshi, et al.
Publicado: (2022) -
Complete Response to Enfortumab Vedotin in a Hemodialysis Patient with Metastatic Urothelial Carcinoma: A Case Report
por: Isoda, Bunpei, et al.
Publicado: (2023)